ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,687, issued on July 21, was assigned to FOGHORN THERAPEUTICS INC. (Watertown, Mass.).

"Compounds and uses thereof" was invented by Sabine K. Ruppel (Cambridge, Mass.), Zhaoxia Yang (Belmont, Mass.), Jason T. Lowe (East Bridgewater, Mass.), Johannes H. Voigt (Cambridge, Mass.), Matthew Netherton (Cambridge, Mass.) and Francois Brucelle (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections."

The patent was filed on Jan. 29, 2020, under Application No. 17/425,013.

*For further information, including image...